Project
avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for NFIX_NFIB
Z-value: 11.34
Motif logo
Transcription factors associated with NFIX_NFIB
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
NFIX
|
ENSG00000008441.18 | NFIX |
|
NFIB
|
ENSG00000147862.17 | NFIB |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| NFIB | hg38_v1_chr9_-_14307928_14308073 | 0.43 | 2.6e-11 | Click! |
| NFIX | hg38_v1_chr19_+_13024917_13024972, hg38_v1_chr19_+_12995554_12995608, hg38_v1_chr19_+_13023958_13024032, hg38_v1_chr19_+_12995467_12995500 | 0.30 | 6.3e-06 | Click! |
Activity profile of NFIX_NFIB motif
Sorted Z-values of NFIX_NFIB motif
Network of associatons between targets according to the STRING database.
First level regulatory network of NFIX_NFIB
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 24.5 | 73.5 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 14.3 | 42.8 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 14.1 | 56.3 | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 12.8 | 38.4 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 11.6 | 34.8 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 10.7 | 53.4 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 9.9 | 49.7 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 9.6 | 38.4 | GO:1903294 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
| 9.6 | 28.7 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 9.4 | 28.3 | GO:0036292 | DNA rewinding(GO:0036292) |
| 9.3 | 37.1 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 9.0 | 36.0 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 8.5 | 8.5 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 8.4 | 25.1 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 8.3 | 24.8 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 8.1 | 24.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 7.6 | 30.3 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 7.4 | 29.6 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 7.3 | 36.4 | GO:1903906 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 7.2 | 14.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 7.1 | 21.4 | GO:0072248 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 7.1 | 35.3 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 7.0 | 21.1 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) |
| 6.9 | 27.8 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 6.9 | 27.8 | GO:1903633 | regulation of calcium-dependent ATPase activity(GO:1903610) negative regulation of calcium-dependent ATPase activity(GO:1903611) regulation of dUTP diphosphatase activity(GO:1903627) positive regulation of dUTP diphosphatase activity(GO:1903629) negative regulation of aminoacyl-tRNA ligase activity(GO:1903631) regulation of leucine-tRNA ligase activity(GO:1903633) negative regulation of leucine-tRNA ligase activity(GO:1903634) |
| 6.7 | 26.8 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 6.6 | 33.2 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 6.4 | 122.3 | GO:0015671 | oxygen transport(GO:0015671) |
| 6.4 | 70.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 6.4 | 12.8 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 6.3 | 25.4 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 6.3 | 37.8 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 6.1 | 18.3 | GO:0051941 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 6.1 | 18.3 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 6.1 | 72.8 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 6.1 | 18.2 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 6.0 | 30.1 | GO:0035106 | operant conditioning(GO:0035106) |
| 6.0 | 101.9 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 6.0 | 17.9 | GO:1903892 | negative regulation of ATF6-mediated unfolded protein response(GO:1903892) |
| 5.9 | 29.5 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 5.9 | 17.6 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 5.7 | 34.2 | GO:0035604 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
| 5.6 | 50.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 5.6 | 16.9 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 5.6 | 16.8 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 5.6 | 22.3 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 5.5 | 16.5 | GO:0051939 | gamma-aminobutyric acid import(GO:0051939) |
| 5.4 | 5.4 | GO:0061517 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) |
| 5.3 | 15.9 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 5.3 | 36.9 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 5.2 | 15.7 | GO:0061027 | umbilical cord morphogenesis(GO:0036304) umbilical cord development(GO:0061027) |
| 5.1 | 56.5 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 5.0 | 15.0 | GO:0001300 | chronological cell aging(GO:0001300) |
| 5.0 | 25.0 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 4.9 | 44.5 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 4.9 | 4.9 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
| 4.9 | 19.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 4.8 | 29.0 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
| 4.8 | 14.4 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 4.7 | 33.1 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
| 4.7 | 4.7 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 4.7 | 84.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 4.7 | 14.1 | GO:0060005 | vestibular reflex(GO:0060005) |
| 4.7 | 28.0 | GO:0060157 | urinary bladder development(GO:0060157) |
| 4.6 | 74.0 | GO:0032060 | bleb assembly(GO:0032060) |
| 4.6 | 13.7 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 4.6 | 4.6 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 4.5 | 8.9 | GO:1902623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 4.4 | 35.6 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 4.4 | 22.0 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 4.4 | 13.1 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
| 4.3 | 17.3 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 4.3 | 55.8 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 4.3 | 25.7 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 4.3 | 17.1 | GO:0018032 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 4.2 | 12.7 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 4.2 | 12.6 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 4.2 | 33.4 | GO:0015705 | iodide transport(GO:0015705) |
| 4.2 | 20.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 4.1 | 12.4 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 4.1 | 16.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 4.1 | 37.2 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 4.1 | 12.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 4.0 | 20.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 4.0 | 8.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 4.0 | 12.1 | GO:0014873 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
| 4.0 | 16.0 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 4.0 | 4.0 | GO:0048243 | norepinephrine secretion(GO:0048243) |
| 4.0 | 12.0 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
| 4.0 | 19.9 | GO:0030070 | insulin processing(GO:0030070) |
| 4.0 | 15.9 | GO:1904141 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 3.9 | 19.6 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 3.9 | 3.9 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
| 3.9 | 7.7 | GO:2000583 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 3.9 | 11.6 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
| 3.9 | 7.7 | GO:1902722 | positive regulation of prolactin secretion(GO:1902722) |
| 3.8 | 3.8 | GO:0005985 | sucrose metabolic process(GO:0005985) |
| 3.8 | 7.6 | GO:0043465 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 3.8 | 15.0 | GO:0071231 | cellular response to folic acid(GO:0071231) |
| 3.7 | 26.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 3.7 | 14.9 | GO:0072166 | posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 3.7 | 18.6 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 3.7 | 7.4 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 3.7 | 3.7 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 3.7 | 22.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 3.7 | 11.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 3.6 | 25.4 | GO:0099550 | trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
| 3.6 | 21.7 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 3.6 | 7.1 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 3.5 | 7.1 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
| 3.5 | 3.5 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 3.5 | 24.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 3.5 | 14.1 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 3.5 | 49.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 3.5 | 69.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 3.5 | 10.4 | GO:2000866 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 3.5 | 3.5 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 3.5 | 10.4 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 3.5 | 10.4 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
| 3.4 | 3.4 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 3.4 | 13.8 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 3.4 | 10.3 | GO:0007525 | somatic muscle development(GO:0007525) |
| 3.4 | 10.3 | GO:0032888 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 3.4 | 10.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 3.4 | 6.8 | GO:0036101 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 3.4 | 3.4 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 3.4 | 67.2 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
| 3.3 | 9.9 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 3.3 | 13.2 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 3.3 | 13.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 3.3 | 26.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 3.3 | 3.3 | GO:0072134 | nephrogenic mesenchyme morphogenesis(GO:0072134) |
| 3.3 | 3.3 | GO:0035801 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
| 3.3 | 9.8 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 3.2 | 55.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 3.2 | 25.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 3.2 | 9.7 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 3.2 | 12.9 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 3.2 | 9.7 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 3.2 | 22.5 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 3.2 | 9.6 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 3.2 | 9.6 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
| 3.2 | 3.2 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 3.2 | 25.4 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 3.2 | 9.5 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 3.1 | 40.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 3.1 | 56.4 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 3.1 | 9.3 | GO:0071529 | cementum mineralization(GO:0071529) |
| 3.1 | 21.4 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
| 3.0 | 9.1 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 3.0 | 6.0 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 3.0 | 11.9 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 3.0 | 8.9 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 2.9 | 35.3 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 2.9 | 14.7 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 2.9 | 8.7 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 2.9 | 8.7 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
| 2.9 | 28.8 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 2.9 | 23.0 | GO:0006531 | aspartate metabolic process(GO:0006531) |
| 2.9 | 8.6 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 2.9 | 2.9 | GO:2001302 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 2.8 | 11.4 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) negative regulation of G-protein coupled receptor internalization(GO:1904021) |
| 2.8 | 28.2 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 2.8 | 16.9 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 2.8 | 41.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 2.8 | 19.5 | GO:0046618 | drug export(GO:0046618) |
| 2.8 | 8.4 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 2.8 | 22.3 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 2.8 | 11.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 2.8 | 8.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 2.8 | 19.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 2.8 | 11.0 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 2.7 | 16.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 2.7 | 24.6 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 2.7 | 5.5 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
| 2.7 | 21.9 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 2.7 | 2.7 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 2.7 | 10.9 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
| 2.7 | 51.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 2.7 | 21.7 | GO:0042737 | drug catabolic process(GO:0042737) |
| 2.7 | 18.9 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 2.7 | 8.0 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
| 2.6 | 23.8 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 2.6 | 2.6 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
| 2.6 | 2.6 | GO:0051610 | serotonin uptake(GO:0051610) |
| 2.6 | 10.6 | GO:0019477 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 2.6 | 7.9 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 2.6 | 7.9 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 2.6 | 2.6 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 2.6 | 10.5 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 2.6 | 15.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 2.6 | 26.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 2.6 | 13.0 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
| 2.6 | 5.2 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 2.6 | 18.1 | GO:0036018 | cellular response to erythropoietin(GO:0036018) |
| 2.6 | 2.6 | GO:0014809 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) regulation of skeletal muscle contraction(GO:0014819) |
| 2.6 | 7.7 | GO:0099612 | protein localization to juxtaparanode region of axon(GO:0071205) protein localization to axon(GO:0099612) |
| 2.6 | 10.3 | GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 2.6 | 15.4 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 2.6 | 7.7 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 2.5 | 35.6 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 2.5 | 2.5 | GO:0070471 | uterine smooth muscle contraction(GO:0070471) |
| 2.5 | 15.2 | GO:0030913 | paranodal junction assembly(GO:0030913) |
| 2.5 | 45.5 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 2.5 | 17.7 | GO:0048241 | epinephrine transport(GO:0048241) |
| 2.5 | 5.0 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
| 2.5 | 10.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 2.5 | 27.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 2.5 | 5.0 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 2.5 | 7.5 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 2.5 | 49.5 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 2.5 | 4.9 | GO:0001755 | neural crest cell migration(GO:0001755) |
| 2.5 | 2.5 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 2.5 | 4.9 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 2.4 | 12.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 2.4 | 2.4 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 2.4 | 9.7 | GO:0002215 | defense response to nematode(GO:0002215) |
| 2.4 | 14.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 2.4 | 9.7 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 2.4 | 4.8 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 2.4 | 4.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 2.4 | 4.8 | GO:1904640 | response to methionine(GO:1904640) |
| 2.4 | 62.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 2.4 | 9.6 | GO:0070316 | regulation of G0 to G1 transition(GO:0070316) |
| 2.4 | 12.0 | GO:1903935 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
| 2.4 | 7.2 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 2.4 | 7.1 | GO:0006683 | galactosylceramide catabolic process(GO:0006683) |
| 2.4 | 11.8 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 2.4 | 14.1 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 2.3 | 16.4 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 2.3 | 2.3 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
| 2.3 | 9.3 | GO:0097491 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 2.3 | 9.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 2.3 | 9.3 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 2.3 | 9.3 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 2.3 | 4.6 | GO:0061184 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) positive regulation of dermatome development(GO:0061184) |
| 2.3 | 25.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 2.3 | 25.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 2.3 | 9.2 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
| 2.3 | 11.5 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 2.3 | 2.3 | GO:0036017 | response to erythropoietin(GO:0036017) |
| 2.3 | 39.0 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 2.3 | 34.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 2.3 | 6.8 | GO:0042560 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 2.3 | 2.3 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 2.3 | 34.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 2.3 | 40.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 2.3 | 4.5 | GO:0032431 | positive regulation of phospholipase A2 activity(GO:0032430) activation of phospholipase A2 activity(GO:0032431) |
| 2.3 | 15.8 | GO:0007000 | nucleolus organization(GO:0007000) |
| 2.2 | 26.9 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 2.2 | 11.2 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 2.2 | 2.2 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 2.2 | 2.2 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 2.2 | 6.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 2.2 | 20.0 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 2.2 | 22.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 2.2 | 4.4 | GO:0007538 | primary sex determination(GO:0007538) |
| 2.2 | 8.8 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
| 2.2 | 6.6 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 2.2 | 8.7 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 2.2 | 4.3 | GO:0019836 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) maintenance of mitochondrion location(GO:0051659) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 2.2 | 4.3 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 2.1 | 12.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 2.1 | 6.4 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
| 2.1 | 6.4 | GO:1904692 | positive regulation of type B pancreatic cell proliferation(GO:1904692) |
| 2.1 | 12.7 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
| 2.1 | 8.4 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 2.1 | 8.4 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 2.1 | 18.9 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
| 2.1 | 8.4 | GO:0010652 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 2.1 | 4.2 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) negative regulation of lamellipodium organization(GO:1902744) |
| 2.1 | 8.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 2.1 | 8.3 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 2.1 | 10.3 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 2.1 | 8.3 | GO:0050957 | equilibrioception(GO:0050957) |
| 2.1 | 37.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 2.1 | 4.1 | GO:0002118 | aggressive behavior(GO:0002118) |
| 2.0 | 16.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 2.0 | 6.1 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 2.0 | 81.6 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 2.0 | 12.2 | GO:0044266 | angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
| 2.0 | 8.1 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 2.0 | 4.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 2.0 | 18.1 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 2.0 | 6.0 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 2.0 | 6.0 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 2.0 | 33.8 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 2.0 | 7.9 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 2.0 | 5.9 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
| 2.0 | 41.3 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 2.0 | 5.9 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 1.9 | 5.8 | GO:1990918 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
| 1.9 | 5.8 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 1.9 | 7.8 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
| 1.9 | 5.8 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 1.9 | 21.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 1.9 | 29.0 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 1.9 | 5.8 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 1.9 | 5.8 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 1.9 | 9.6 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 1.9 | 5.8 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 1.9 | 11.5 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
| 1.9 | 9.5 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 1.9 | 1.9 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
| 1.9 | 5.7 | GO:0090274 | regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
| 1.9 | 13.2 | GO:0051552 | flavone metabolic process(GO:0051552) |
| 1.9 | 57.8 | GO:0098743 | cell aggregation(GO:0098743) |
| 1.9 | 16.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 1.8 | 9.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 1.8 | 5.5 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 1.8 | 5.5 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 1.8 | 7.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 1.8 | 7.2 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
| 1.8 | 10.7 | GO:0006565 | L-serine catabolic process(GO:0006565) |
| 1.8 | 3.6 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 1.8 | 12.3 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
| 1.8 | 1.8 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
| 1.8 | 8.8 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
| 1.8 | 17.6 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 1.7 | 5.2 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 1.7 | 32.9 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 1.7 | 5.2 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 1.7 | 5.2 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 1.7 | 12.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 1.7 | 3.4 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 1.7 | 6.8 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 1.7 | 5.1 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 1.7 | 3.4 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 1.7 | 5.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 1.7 | 3.4 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
| 1.7 | 43.4 | GO:0015695 | organic cation transport(GO:0015695) |
| 1.7 | 3.3 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 1.7 | 13.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 1.7 | 3.3 | GO:0046959 | habituation(GO:0046959) |
| 1.6 | 24.7 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
| 1.6 | 3.3 | GO:0071072 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) negative regulation of phospholipid biosynthetic process(GO:0071072) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 1.6 | 1.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 1.6 | 9.8 | GO:0008218 | bioluminescence(GO:0008218) |
| 1.6 | 8.1 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 1.6 | 4.9 | GO:1903567 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 1.6 | 4.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 1.6 | 8.0 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 1.6 | 4.8 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 1.6 | 3.2 | GO:0097325 | melanocyte proliferation(GO:0097325) |
| 1.6 | 9.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 1.6 | 4.8 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 1.6 | 14.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 1.6 | 7.9 | GO:0035645 | enteric smooth muscle cell differentiation(GO:0035645) |
| 1.6 | 28.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 1.6 | 4.7 | GO:2000317 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 1.6 | 4.7 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 1.6 | 23.3 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
| 1.5 | 4.6 | GO:1990637 | response to prolactin(GO:1990637) |
| 1.5 | 6.2 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 1.5 | 7.7 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 1.5 | 13.8 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 1.5 | 15.3 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 1.5 | 13.8 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 1.5 | 13.7 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 1.5 | 1.5 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 1.5 | 7.6 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 1.5 | 1.5 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
| 1.5 | 3.0 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
| 1.5 | 4.5 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 1.5 | 4.5 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 1.5 | 25.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
| 1.5 | 1.5 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 1.5 | 7.5 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 1.5 | 5.9 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 1.5 | 13.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 1.5 | 1.5 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 1.5 | 19.2 | GO:2000194 | regulation of female gonad development(GO:2000194) |
| 1.5 | 7.3 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 1.5 | 2.9 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 1.5 | 11.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 1.5 | 14.5 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 1.4 | 10.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 1.4 | 4.3 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 1.4 | 4.3 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 1.4 | 12.8 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 1.4 | 14.2 | GO:0060736 | prostate gland growth(GO:0060736) |
| 1.4 | 4.3 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
| 1.4 | 8.5 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 1.4 | 8.4 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 1.4 | 7.0 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 1.4 | 11.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 1.4 | 4.2 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 1.4 | 1.4 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 1.4 | 11.1 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 1.4 | 4.2 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 1.4 | 8.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 1.4 | 5.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 1.4 | 19.4 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 1.4 | 21.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 1.4 | 2.7 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 1.4 | 4.1 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 1.4 | 8.2 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 1.4 | 36.7 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 1.4 | 19.0 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 1.4 | 9.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 1.3 | 16.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 1.3 | 1.3 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
| 1.3 | 6.7 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
| 1.3 | 9.3 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 1.3 | 9.3 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 1.3 | 17.1 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) |
| 1.3 | 5.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 1.3 | 4.0 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 1.3 | 15.8 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 1.3 | 2.6 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
| 1.3 | 11.8 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 1.3 | 2.6 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
| 1.3 | 9.2 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 1.3 | 13.1 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 1.3 | 7.8 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 1.3 | 6.5 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 1.3 | 3.9 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
| 1.3 | 9.1 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 1.3 | 5.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 1.3 | 6.5 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 1.3 | 5.2 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 1.3 | 20.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 1.3 | 2.6 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 1.3 | 1.3 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 1.3 | 7.7 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 1.3 | 3.8 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
| 1.3 | 3.8 | GO:0019605 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
| 1.3 | 6.4 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 1.3 | 5.1 | GO:0015793 | glycerol transport(GO:0015793) |
| 1.3 | 10.2 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 1.3 | 8.8 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 1.3 | 31.5 | GO:0007398 | ectoderm development(GO:0007398) |
| 1.3 | 13.8 | GO:0097107 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 1.3 | 12.6 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 1.3 | 3.8 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
| 1.2 | 22.4 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 1.2 | 8.7 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
| 1.2 | 7.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 1.2 | 7.2 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 1.2 | 22.8 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 1.2 | 3.6 | GO:0019557 | formate metabolic process(GO:0015942) histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 1.2 | 2.4 | GO:0072011 | glomerular endothelium development(GO:0072011) |
| 1.2 | 32.0 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
| 1.2 | 8.3 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 1.2 | 15.4 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 1.2 | 3.5 | GO:0009183 | ADP biosynthetic process(GO:0006172) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 1.2 | 7.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 1.2 | 2.4 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 1.2 | 12.9 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 1.2 | 36.3 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 1.2 | 8.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 1.2 | 12.9 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 1.2 | 4.7 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 1.2 | 33.8 | GO:0010039 | response to iron ion(GO:0010039) |
| 1.2 | 13.9 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 1.2 | 24.3 | GO:0014850 | response to muscle activity(GO:0014850) |
| 1.2 | 4.6 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 1.2 | 3.5 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 1.2 | 20.7 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 1.2 | 3.5 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 1.2 | 51.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 1.1 | 18.4 | GO:0007141 | male meiosis I(GO:0007141) |
| 1.1 | 12.6 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 1.1 | 5.7 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 1.1 | 12.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.1 | 2.3 | GO:0042161 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 1.1 | 5.7 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 1.1 | 5.7 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 1.1 | 71.6 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 1.1 | 6.8 | GO:0019732 | antifungal humoral response(GO:0019732) |
| 1.1 | 5.7 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 1.1 | 14.7 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 1.1 | 10.2 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 1.1 | 9.0 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 1.1 | 6.7 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 1.1 | 8.9 | GO:0035640 | exploration behavior(GO:0035640) |
| 1.1 | 3.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 1.1 | 4.5 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 1.1 | 2.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 1.1 | 27.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 1.1 | 3.3 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 1.1 | 2.2 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 1.1 | 5.5 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 1.1 | 2.2 | GO:0044805 | late nucleophagy(GO:0044805) |
| 1.1 | 19.6 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 1.1 | 7.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 1.1 | 2.2 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 1.1 | 16.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 1.1 | 4.3 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 1.1 | 20.5 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 1.1 | 5.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 1.1 | 15.0 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 1.1 | 17.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 1.1 | 12.8 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
| 1.1 | 1.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 1.1 | 15.8 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 1.0 | 4.2 | GO:0009956 | radial pattern formation(GO:0009956) |
| 1.0 | 6.2 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 1.0 | 4.2 | GO:1990834 | response to odorant(GO:1990834) |
| 1.0 | 10.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 1.0 | 4.1 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 1.0 | 14.5 | GO:0070528 | protein kinase C signaling(GO:0070528) |
| 1.0 | 1.0 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 1.0 | 2.0 | GO:0034201 | response to oleic acid(GO:0034201) |
| 1.0 | 4.1 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 1.0 | 16.2 | GO:0003334 | keratinocyte development(GO:0003334) |
| 1.0 | 2.0 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
| 1.0 | 8.0 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 1.0 | 5.0 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
| 1.0 | 16.1 | GO:0046697 | decidualization(GO:0046697) |
| 1.0 | 5.0 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 1.0 | 2.0 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
| 1.0 | 22.0 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 1.0 | 2.0 | GO:1902617 | response to fluoride(GO:1902617) |
| 1.0 | 3.0 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 1.0 | 11.9 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 1.0 | 19.8 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 1.0 | 4.0 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 1.0 | 1.0 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 1.0 | 4.9 | GO:0070781 | response to biotin(GO:0070781) |
| 1.0 | 1.0 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
| 1.0 | 2.9 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 1.0 | 5.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 1.0 | 2.9 | GO:0019075 | virus maturation(GO:0019075) |
| 1.0 | 7.7 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 1.0 | 2.9 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 1.0 | 9.5 | GO:1903350 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.9 | 2.8 | GO:0071810 | circadian temperature homeostasis(GO:0060086) regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.9 | 3.8 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.9 | 0.9 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
| 0.9 | 22.7 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.9 | 3.8 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.9 | 4.7 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.9 | 9.4 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.9 | 2.8 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.9 | 4.7 | GO:1901090 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.9 | 37.4 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
| 0.9 | 0.9 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.9 | 5.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
| 0.9 | 8.4 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
| 0.9 | 3.7 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.9 | 6.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.9 | 7.3 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.9 | 7.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.9 | 0.9 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.9 | 21.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.9 | 5.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
| 0.9 | 8.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.9 | 6.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.9 | 9.0 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
| 0.9 | 4.5 | GO:0046520 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.9 | 9.0 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.9 | 9.0 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.9 | 25.1 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.9 | 2.7 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
| 0.9 | 3.6 | GO:0003188 | heart valve formation(GO:0003188) |
| 0.9 | 4.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.9 | 0.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.9 | 8.8 | GO:0035878 | nail development(GO:0035878) |
| 0.9 | 17.6 | GO:0072538 | T-helper 17 type immune response(GO:0072538) |
| 0.9 | 0.9 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
| 0.9 | 6.1 | GO:0042426 | choline catabolic process(GO:0042426) |
| 0.9 | 2.6 | GO:0010460 | positive regulation of heart rate(GO:0010460) |
| 0.9 | 4.3 | GO:0021997 | neural plate axis specification(GO:0021997) |
| 0.9 | 9.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.8 | 4.2 | GO:1901678 | iron coordination entity transport(GO:1901678) |
| 0.8 | 2.5 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.8 | 2.5 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.8 | 1.7 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.8 | 1.7 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.8 | 2.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.8 | 10.0 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.8 | 22.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.8 | 4.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.8 | 7.5 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.8 | 1.7 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 0.8 | 8.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
| 0.8 | 2.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
| 0.8 | 4.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
| 0.8 | 2.5 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.8 | 6.6 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.8 | 7.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.8 | 14.6 | GO:0048753 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
| 0.8 | 6.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.8 | 23.2 | GO:0008038 | neuron recognition(GO:0008038) |
| 0.8 | 3.2 | GO:1904970 | brush border assembly(GO:1904970) |
| 0.8 | 3.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.8 | 8.0 | GO:0046688 | response to copper ion(GO:0046688) |
| 0.8 | 2.4 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
| 0.8 | 4.7 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.8 | 2.4 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.8 | 3.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.8 | 7.1 | GO:0034465 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) response to carbon monoxide(GO:0034465) |
| 0.8 | 0.8 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.8 | 3.9 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 0.8 | 6.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.8 | 2.3 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
| 0.8 | 12.3 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.8 | 3.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.8 | 0.8 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.8 | 1.5 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
| 0.8 | 4.6 | GO:0035989 | tendon development(GO:0035989) |
| 0.8 | 20.5 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.8 | 1.5 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.8 | 12.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.8 | 4.5 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.8 | 104.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.8 | 1.5 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) regulation of axon extension involved in axon guidance(GO:0048841) |
| 0.8 | 3.0 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.7 | 4.5 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.7 | 3.7 | GO:0021794 | thalamus development(GO:0021794) |
| 0.7 | 2.2 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.7 | 0.7 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
| 0.7 | 4.5 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.7 | 3.0 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.7 | 2.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.7 | 4.4 | GO:0060037 | pharyngeal system development(GO:0060037) |
| 0.7 | 17.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.7 | 10.3 | GO:0006833 | water transport(GO:0006833) |
| 0.7 | 6.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.7 | 16.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.7 | 14.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.7 | 5.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
| 0.7 | 2.2 | GO:0051970 | negative regulation of action potential(GO:0045759) negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.7 | 2.9 | GO:0030200 | proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.7 | 2.2 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.7 | 9.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.7 | 3.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.7 | 1.4 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.7 | 2.1 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
| 0.7 | 1.4 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 0.7 | 8.5 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.7 | 1.4 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.7 | 6.4 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.7 | 1.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.7 | 4.2 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.7 | 9.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.7 | 0.7 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.7 | 2.8 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.7 | 6.3 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
| 0.7 | 2.7 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.7 | 6.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.7 | 8.2 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.7 | 6.1 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
| 0.7 | 4.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.7 | 2.7 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.7 | 8.7 | GO:0006706 | steroid catabolic process(GO:0006706) |
| 0.7 | 9.4 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
| 0.7 | 8.0 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.7 | 1.3 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
| 0.7 | 2.7 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
| 0.7 | 2.0 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.7 | 2.7 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 0.7 | 8.6 | GO:0001825 | blastocyst formation(GO:0001825) |
| 0.7 | 5.9 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
| 0.7 | 5.3 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.7 | 2.0 | GO:0034505 | tooth mineralization(GO:0034505) |
| 0.7 | 5.2 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.7 | 8.5 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.6 | 4.5 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.6 | 1.9 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.6 | 4.5 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.6 | 2.6 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.6 | 3.8 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 0.6 | 3.8 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
| 0.6 | 7.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.6 | 1.3 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
| 0.6 | 3.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.6 | 14.4 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
| 0.6 | 16.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.6 | 3.1 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.6 | 2.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.6 | 1.8 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.6 | 9.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.6 | 3.1 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.6 | 23.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.6 | 2.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.6 | 3.6 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
| 0.6 | 0.6 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.6 | 5.4 | GO:0030238 | male sex determination(GO:0030238) |
| 0.6 | 11.4 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.6 | 4.2 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.6 | 2.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.6 | 4.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.6 | 7.7 | GO:0019731 | antibacterial humoral response(GO:0019731) |
| 0.6 | 4.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 0.6 | 1.2 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
| 0.6 | 58.4 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.6 | 7.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.6 | 26.4 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.6 | 4.1 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.6 | 1.8 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.6 | 12.8 | GO:0048854 | brain morphogenesis(GO:0048854) |
| 0.6 | 2.3 | GO:0035627 | ceramide transport(GO:0035627) |
| 0.6 | 1.2 | GO:0021780 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.6 | 5.8 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.6 | 12.1 | GO:0007616 | long-term memory(GO:0007616) |
| 0.6 | 1.2 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.6 | 4.6 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.6 | 4.6 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 0.6 | 4.6 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) positive regulation of T-helper 1 cell differentiation(GO:0045627) |
| 0.6 | 3.4 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.6 | 6.8 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.6 | 5.1 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.6 | 1.7 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.6 | 1.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.6 | 19.7 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
| 0.6 | 0.6 | GO:0051891 | regulation of cardioblast differentiation(GO:0051890) positive regulation of cardioblast differentiation(GO:0051891) |
| 0.6 | 29.6 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.6 | 7.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.6 | 2.8 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.6 | 2.2 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.5 | 4.9 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.5 | 4.9 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.5 | 2.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
| 0.5 | 2.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 0.5 | 1.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.5 | 5.9 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.5 | 12.3 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.5 | 3.2 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 0.5 | 4.2 | GO:0061709 | reticulophagy(GO:0061709) |
| 0.5 | 4.8 | GO:0031643 | positive regulation of myelination(GO:0031643) |
| 0.5 | 2.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.5 | 8.8 | GO:0036065 | fucosylation(GO:0036065) |
| 0.5 | 20.8 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
| 0.5 | 23.4 | GO:0007602 | phototransduction(GO:0007602) |
| 0.5 | 6.7 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.5 | 12.9 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
| 0.5 | 10.2 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
| 0.5 | 1.0 | GO:0061743 | motor learning(GO:0061743) |
| 0.5 | 2.0 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.5 | 1.5 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) positive regulation of fibril organization(GO:1902905) |
| 0.5 | 54.5 | GO:0006821 | chloride transport(GO:0006821) |
| 0.5 | 5.9 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
| 0.5 | 1.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
| 0.5 | 17.7 | GO:0019233 | sensory perception of pain(GO:0019233) |
| 0.5 | 4.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.5 | 7.4 | GO:0007608 | sensory perception of smell(GO:0007608) |
| 0.5 | 2.0 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.5 | 2.4 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.5 | 2.4 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.5 | 3.4 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.5 | 1.0 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 0.5 | 2.9 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.5 | 3.8 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.5 | 2.4 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.5 | 0.9 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.5 | 2.4 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.5 | 1.9 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
| 0.5 | 2.8 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.5 | 1.9 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
| 0.5 | 24.9 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.5 | 1.9 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.5 | 1.9 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.5 | 6.9 | GO:0021542 | dentate gyrus development(GO:0021542) |
| 0.5 | 0.9 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.5 | 2.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.5 | 2.7 | GO:0048265 | response to pain(GO:0048265) |
| 0.5 | 1.8 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.5 | 4.1 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.4 | 1.8 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.4 | 2.2 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
| 0.4 | 21.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.4 | 1.8 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.4 | 2.2 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.4 | 4.4 | GO:0035082 | axoneme assembly(GO:0035082) |
| 0.4 | 1.3 | GO:0032328 | alanine transport(GO:0032328) |
| 0.4 | 0.9 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.4 | 0.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.4 | 0.9 | GO:0042414 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.4 | 3.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.4 | 5.6 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.4 | 39.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.4 | 0.8 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.4 | 6.3 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.4 | 5.4 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.4 | 3.3 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.4 | 3.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.4 | 11.0 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.4 | 4.9 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.4 | 2.4 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.4 | 2.4 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.4 | 2.4 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.4 | 2.0 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 0.4 | 4.0 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
| 0.4 | 1.2 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.4 | 0.4 | GO:0060896 | neural plate pattern specification(GO:0060896) |
| 0.4 | 2.0 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.4 | 0.4 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
| 0.4 | 2.7 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.4 | 3.8 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.4 | 4.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
| 0.4 | 7.5 | GO:0097178 | ruffle assembly(GO:0097178) |
| 0.4 | 13.6 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.4 | 3.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.4 | 4.8 | GO:0021954 | central nervous system neuron development(GO:0021954) |
| 0.4 | 5.5 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.4 | 1.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.4 | 4.4 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
| 0.4 | 2.5 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.4 | 1.1 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.4 | 0.4 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
| 0.4 | 1.4 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.4 | 4.6 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
| 0.3 | 1.7 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
| 0.3 | 3.8 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
| 0.3 | 1.7 | GO:0048484 | enteric nervous system development(GO:0048484) |
| 0.3 | 22.0 | GO:0007586 | digestion(GO:0007586) |
| 0.3 | 40.5 | GO:0044782 | cilium organization(GO:0044782) |
| 0.3 | 11.6 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
| 0.3 | 1.4 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.3 | 1.7 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.3 | 1.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.3 | 3.3 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.3 | 10.5 | GO:0015918 | sterol transport(GO:0015918) |
| 0.3 | 1.9 | GO:0071692 | sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.3 | 3.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.3 | 16.3 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
| 0.3 | 1.6 | GO:2000143 | negative regulation of DNA-templated transcription, initiation(GO:2000143) |
| 0.3 | 1.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.3 | 1.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.3 | 3.1 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
| 0.3 | 1.5 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
| 0.3 | 0.6 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 0.3 | 3.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.3 | 2.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
| 0.3 | 10.3 | GO:0032760 | positive regulation of tumor necrosis factor production(GO:0032760) |
| 0.3 | 1.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.3 | 2.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.3 | 1.2 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
| 0.3 | 8.0 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.3 | 2.6 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.3 | 6.6 | GO:0016101 | diterpenoid metabolic process(GO:0016101) |
| 0.3 | 1.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.3 | 0.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.3 | 1.1 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.3 | 3.6 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.3 | 5.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.3 | 1.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.3 | 2.8 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
| 0.3 | 0.6 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.3 | 1.4 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.3 | 7.6 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.3 | 1.1 | GO:0007512 | adult heart development(GO:0007512) |
| 0.3 | 6.5 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.3 | 0.5 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.3 | 1.8 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.3 | 1.5 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
| 0.3 | 0.8 | GO:0090197 | positive regulation of chemokine secretion(GO:0090197) |
| 0.3 | 4.8 | GO:0031280 | negative regulation of cyclase activity(GO:0031280) |
| 0.2 | 1.2 | GO:0003091 | renal water homeostasis(GO:0003091) |
| 0.2 | 1.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.2 | 4.2 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
| 0.2 | 0.7 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
| 0.2 | 1.7 | GO:0097205 | renal filtration(GO:0097205) |
| 0.2 | 0.5 | GO:0030647 | aminoglycoside antibiotic metabolic process(GO:0030647) |
| 0.2 | 7.8 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.2 | 1.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.2 | 4.2 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.2 | 2.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.2 | 0.7 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.2 | 0.5 | GO:0061056 | sclerotome development(GO:0061056) |
| 0.2 | 3.8 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
| 0.2 | 6.5 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.2 | 0.2 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.2 | 0.4 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.2 | 1.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.2 | 0.7 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.2 | 3.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.2 | 1.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.2 | 2.8 | GO:0045008 | depyrimidination(GO:0045008) |
| 0.2 | 1.1 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.2 | 1.7 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.2 | 2.0 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.2 | 1.2 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.2 | 0.4 | GO:0015824 | proline transport(GO:0015824) |
| 0.2 | 0.8 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.2 | 2.7 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
| 0.2 | 1.7 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.2 | 1.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.2 | 8.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.2 | 1.1 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) |
| 0.2 | 5.7 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.2 | 0.8 | GO:0038194 | thyroid-stimulating hormone signaling pathway(GO:0038194) cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.2 | 1.1 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.2 | 5.5 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
| 0.2 | 1.3 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 0.2 | 0.7 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.2 | 0.9 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.2 | 1.4 | GO:0071625 | vocalization behavior(GO:0071625) |
| 0.2 | 1.7 | GO:0001945 | lymph vessel development(GO:0001945) |
| 0.2 | 2.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.2 | 1.4 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
| 0.2 | 0.7 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.2 | 0.5 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 0.2 | 0.6 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
| 0.2 | 2.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.2 | 1.1 | GO:0071265 | L-methionine biosynthetic process(GO:0071265) |
| 0.2 | 1.2 | GO:0008347 | glial cell migration(GO:0008347) |
| 0.2 | 0.3 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
| 0.1 | 0.6 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 | 1.6 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
| 0.1 | 0.6 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.1 | 2.0 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.1 | 1.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.1 | 2.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.1 | 1.8 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
| 0.1 | 0.5 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.1 | 0.6 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) |
| 0.1 | 13.4 | GO:0007411 | axon guidance(GO:0007411) |
| 0.1 | 3.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.1 | 1.1 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
| 0.1 | 0.1 | GO:0001659 | temperature homeostasis(GO:0001659) |
| 0.1 | 0.8 | GO:0033363 | secretory granule organization(GO:0033363) |
| 0.1 | 1.1 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.1 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.1 | 1.9 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.1 | 0.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.1 | 1.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.1 | 5.7 | GO:0070268 | cornification(GO:0070268) |
| 0.1 | 0.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
| 0.1 | 0.7 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 | 0.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.1 | 2.6 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
| 0.1 | 1.2 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
| 0.1 | 0.1 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 0.1 | 0.4 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.1 | 1.0 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.1 | 0.1 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) negative regulation of dendritic cell apoptotic process(GO:2000669) |
| 0.1 | 0.4 | GO:0000050 | urea cycle(GO:0000050) |
| 0.1 | 1.6 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.1 | 1.9 | GO:0007588 | excretion(GO:0007588) |
| 0.1 | 0.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.1 | 0.1 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.1 | 0.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.1 | 0.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 | 0.7 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 0.2 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.0 | 0.3 | GO:0001562 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
| 0.0 | 0.4 | GO:0072348 | sulfur compound transport(GO:0072348) |
| 0.0 | 0.2 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.0 | 0.1 | GO:0002158 | osteoclast proliferation(GO:0002158) |
| 0.0 | 0.2 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
| 0.0 | 0.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
| 0.0 | 0.5 | GO:0048665 | neuron fate specification(GO:0048665) |
| 0.0 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.0 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
| 0.0 | 0.8 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
| 0.0 | 0.2 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.0 | 0.1 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
| 0.0 | 0.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
| 0.0 | 0.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.0 | 0.1 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
| 0.0 | 0.3 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 18.6 | 74.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 14.3 | 71.4 | GO:0001652 | granular component(GO:0001652) |
| 12.7 | 50.8 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 8.3 | 49.9 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 7.3 | 22.0 | GO:0036030 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 7.2 | 7.2 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 7.1 | 21.3 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 5.2 | 77.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 5.1 | 15.3 | GO:0044609 | DBIRD complex(GO:0044609) |
| 4.9 | 64.2 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 4.9 | 14.7 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 4.5 | 77.3 | GO:0033010 | paranodal junction(GO:0033010) |
| 4.5 | 22.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 4.4 | 57.0 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 4.2 | 12.6 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 4.0 | 56.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 4.0 | 19.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 3.9 | 11.8 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 3.8 | 15.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 3.7 | 7.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 3.6 | 10.7 | GO:0070701 | mucus layer(GO:0070701) |
| 3.5 | 10.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 3.5 | 17.4 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 3.4 | 10.3 | GO:0055028 | cortical microtubule(GO:0055028) mitotic spindle astral microtubule(GO:0061673) |
| 3.4 | 27.3 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
| 3.4 | 10.2 | GO:0097229 | sperm end piece(GO:0097229) |
| 3.4 | 30.3 | GO:0071953 | elastic fiber(GO:0071953) |
| 3.4 | 33.5 | GO:0005614 | interstitial matrix(GO:0005614) |
| 3.3 | 13.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 3.3 | 43.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 3.2 | 19.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 3.2 | 19.4 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 3.1 | 6.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 3.1 | 9.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 3.1 | 70.4 | GO:0042627 | chylomicron(GO:0042627) |
| 3.0 | 45.5 | GO:0030478 | actin cap(GO:0030478) |
| 3.0 | 20.9 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 2.9 | 41.2 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 2.9 | 20.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 2.9 | 2.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 2.8 | 16.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 2.8 | 11.1 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 2.7 | 32.1 | GO:0033270 | paranode region of axon(GO:0033270) |
| 2.5 | 20.3 | GO:0005579 | membrane attack complex(GO:0005579) |
| 2.5 | 10.1 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 2.5 | 12.6 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 2.5 | 10.1 | GO:0097513 | myosin II filament(GO:0097513) |
| 2.5 | 22.6 | GO:0043203 | axon hillock(GO:0043203) |
| 2.5 | 22.5 | GO:0033391 | chromatoid body(GO:0033391) |
| 2.5 | 7.4 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 2.4 | 12.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 2.4 | 24.3 | GO:0097440 | apical dendrite(GO:0097440) |
| 2.4 | 9.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 2.4 | 28.9 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 2.4 | 9.6 | GO:0044305 | calyx of Held(GO:0044305) |
| 2.4 | 19.2 | GO:0035976 | AP1 complex(GO:0035976) |
| 2.4 | 31.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 2.4 | 11.9 | GO:0070847 | core mediator complex(GO:0070847) |
| 2.3 | 68.7 | GO:0043218 | compact myelin(GO:0043218) |
| 2.3 | 4.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 2.3 | 33.9 | GO:0005861 | troponin complex(GO:0005861) |
| 2.2 | 15.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 2.2 | 6.6 | GO:0098536 | deuterosome(GO:0098536) |
| 2.1 | 2.1 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 2.1 | 31.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 2.1 | 48.6 | GO:0097386 | glial cell projection(GO:0097386) |
| 2.1 | 37.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 2.1 | 18.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 2.1 | 2.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
| 2.1 | 4.2 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 2.1 | 14.5 | GO:1990745 | EARP complex(GO:1990745) |
| 2.0 | 24.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 2.0 | 18.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 2.0 | 7.8 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 1.9 | 5.7 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 1.9 | 11.3 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 1.9 | 5.6 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 1.9 | 87.8 | GO:0001533 | cornified envelope(GO:0001533) |
| 1.8 | 9.0 | GO:0072534 | perineuronal net(GO:0072534) |
| 1.8 | 8.9 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 1.8 | 5.3 | GO:0033263 | CORVET complex(GO:0033263) |
| 1.7 | 8.7 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 1.7 | 10.3 | GO:0002177 | manchette(GO:0002177) |
| 1.7 | 11.9 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 1.7 | 8.4 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 1.7 | 19.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 1.6 | 11.1 | GO:0036157 | outer dynein arm(GO:0036157) |
| 1.6 | 4.8 | GO:0098831 | cytoskeleton of presynaptic active zone(GO:0048788) presynaptic active zone cytoplasmic component(GO:0098831) presynaptic cytoskeleton(GO:0099569) |
| 1.6 | 4.8 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 1.6 | 3.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 1.5 | 7.7 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 1.5 | 4.6 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 1.5 | 9.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 1.5 | 28.8 | GO:0036038 | MKS complex(GO:0036038) |
| 1.5 | 12.0 | GO:0034464 | BBSome(GO:0034464) |
| 1.5 | 12.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 1.5 | 14.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 1.4 | 2.8 | GO:1990393 | 3M complex(GO:1990393) |
| 1.4 | 8.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 1.4 | 11.2 | GO:0070852 | cell body fiber(GO:0070852) |
| 1.3 | 13.5 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 1.3 | 88.1 | GO:0005796 | Golgi lumen(GO:0005796) |
| 1.3 | 11.9 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 1.3 | 21.0 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 1.3 | 489.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 1.3 | 23.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 1.3 | 5.2 | GO:0000801 | central element(GO:0000801) |
| 1.3 | 5.1 | GO:0070695 | FHF complex(GO:0070695) |
| 1.3 | 24.4 | GO:0016342 | catenin complex(GO:0016342) |
| 1.3 | 6.4 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 1.3 | 3.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
| 1.2 | 30.0 | GO:0005581 | collagen trimer(GO:0005581) |
| 1.2 | 4.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 1.2 | 11.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 1.2 | 22.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 1.2 | 3.6 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 1.2 | 4.8 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 1.2 | 6.0 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 1.2 | 20.9 | GO:0005922 | connexon complex(GO:0005922) |
| 1.2 | 10.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 1.2 | 9.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 1.2 | 5.8 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 1.2 | 21.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 1.1 | 4.5 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 1.1 | 4.5 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 1.1 | 17.8 | GO:0044295 | axonal growth cone(GO:0044295) |
| 1.1 | 11.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 1.1 | 4.4 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 1.1 | 41.7 | GO:0032590 | dendrite membrane(GO:0032590) |
| 1.1 | 12.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 1.1 | 5.4 | GO:0043083 | synaptic cleft(GO:0043083) |
| 1.1 | 9.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 1.1 | 85.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 1.1 | 3.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
| 1.1 | 4.3 | GO:1990879 | CST complex(GO:1990879) |
| 1.0 | 8.4 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 1.0 | 4.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 1.0 | 4.0 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 1.0 | 36.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 1.0 | 3.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 1.0 | 9.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 1.0 | 21.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 1.0 | 2.9 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 1.0 | 72.3 | GO:0005902 | microvillus(GO:0005902) |
| 1.0 | 33.1 | GO:0042629 | mast cell granule(GO:0042629) |
| 1.0 | 2.9 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 1.0 | 3.9 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 1.0 | 20.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 1.0 | 9.6 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 1.0 | 6.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.9 | 2.8 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.9 | 6.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.9 | 4.7 | GO:0005858 | axonemal dynein complex(GO:0005858) |
| 0.9 | 2.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 0.9 | 3.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.8 | 10.0 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.8 | 5.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.8 | 3.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.8 | 34.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.8 | 4.8 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.8 | 26.6 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.8 | 5.5 | GO:0043196 | varicosity(GO:0043196) |
| 0.8 | 14.9 | GO:0071437 | invadopodium(GO:0071437) |
| 0.8 | 5.5 | GO:0005921 | gap junction(GO:0005921) |
| 0.8 | 17.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.8 | 34.8 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.8 | 0.8 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.8 | 3.8 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.7 | 2.2 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.7 | 3.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.7 | 4.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.7 | 3.7 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.7 | 2.9 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
| 0.7 | 11.7 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.7 | 29.9 | GO:0045095 | keratin filament(GO:0045095) |
| 0.7 | 27.0 | GO:0008305 | integrin complex(GO:0008305) |
| 0.7 | 51.7 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.7 | 2.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.7 | 7.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.7 | 16.1 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.7 | 11.2 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.7 | 32.6 | GO:0016235 | aggresome(GO:0016235) |
| 0.7 | 8.3 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.7 | 3.4 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
| 0.7 | 3.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.7 | 15.6 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.7 | 5.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.7 | 4.1 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.7 | 76.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.7 | 46.5 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.7 | 43.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.7 | 2.0 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.7 | 13.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.7 | 9.8 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.7 | 3.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.7 | 7.2 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.6 | 2.6 | GO:0032449 | CBM complex(GO:0032449) |
| 0.6 | 4.5 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.6 | 64.3 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 0.6 | 1.9 | GO:0043293 | apoptosome(GO:0043293) |
| 0.6 | 9.5 | GO:0031045 | dense core granule(GO:0031045) |
| 0.6 | 4.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.6 | 140.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.6 | 16.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.6 | 7.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.6 | 1.2 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.6 | 31.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.6 | 18.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.6 | 4.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.6 | 2.3 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.5 | 6.0 | GO:0001741 | XY body(GO:0001741) |
| 0.5 | 1.6 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.5 | 30.1 | GO:0005776 | autophagosome(GO:0005776) |
| 0.5 | 4.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.5 | 3.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.5 | 4.2 | GO:0030315 | T-tubule(GO:0030315) |
| 0.5 | 4.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.5 | 3.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.5 | 1.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.5 | 19.9 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.5 | 3.6 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.5 | 26.4 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.5 | 16.8 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.5 | 2.4 | GO:0089701 | U2AF(GO:0089701) |
| 0.5 | 25.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.5 | 1.9 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.5 | 24.6 | GO:0005901 | caveola(GO:0005901) |
| 0.5 | 32.7 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.5 | 575.5 | GO:0005615 | extracellular space(GO:0005615) |
| 0.5 | 7.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.5 | 1.4 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
| 0.5 | 5.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.5 | 5.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.5 | 3.7 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.5 | 24.8 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.4 | 31.7 | GO:0031514 | motile cilium(GO:0031514) |
| 0.4 | 615.2 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
| 0.4 | 3.5 | GO:0072487 | MSL complex(GO:0072487) |
| 0.4 | 3.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.4 | 6.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.4 | 25.2 | GO:0005811 | lipid particle(GO:0005811) |
| 0.4 | 0.4 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.4 | 2.3 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.4 | 4.2 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.4 | 5.8 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.3 | 2.7 | GO:0070449 | elongin complex(GO:0070449) |
| 0.3 | 0.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.3 | 3.2 | GO:0097413 | Lewy body(GO:0097413) |
| 0.3 | 3.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.3 | 5.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.3 | 0.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.3 | 0.9 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.3 | 7.0 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.3 | 31.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.3 | 3.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.3 | 15.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.3 | 2.9 | GO:0000786 | nucleosome(GO:0000786) |
| 0.3 | 1.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.3 | 0.8 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
| 0.3 | 2.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.3 | 2.0 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.3 | 11.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.3 | 1.5 | GO:0032009 | early phagosome(GO:0032009) |
| 0.2 | 0.7 | GO:0030689 | Noc complex(GO:0030689) |
| 0.2 | 24.2 | GO:0031674 | I band(GO:0031674) |
| 0.2 | 7.6 | GO:0097546 | ciliary base(GO:0097546) |
| 0.2 | 62.9 | GO:0043025 | neuronal cell body(GO:0043025) |
| 0.2 | 6.0 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.2 | 5.1 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.2 | 2.3 | GO:0032039 | integrator complex(GO:0032039) |
| 0.2 | 3.5 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.2 | 2.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.2 | 487.1 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
| 0.2 | 0.7 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.2 | 1.1 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.1 | 4.7 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 0.7 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.1 | 0.7 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.1 | 1.1 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.1 | 2.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.1 | 0.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.1 | 0.5 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.1 | 0.9 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.1 | 1.0 | GO:0000800 | lateral element(GO:0000800) |
| 0.1 | 4.3 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 0.2 | GO:0030057 | desmosome(GO:0030057) |
| 0.1 | 0.5 | GO:0030990 | intraciliary transport particle(GO:0030990) |
| 0.1 | 0.4 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.1 | 0.4 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.0 | 5.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 19.7 | 59.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
| 15.3 | 46.0 | GO:0035375 | zymogen binding(GO:0035375) |
| 9.6 | 143.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 8.4 | 25.3 | GO:0016497 | substance K receptor activity(GO:0016497) |
| 8.2 | 24.6 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 7.7 | 23.2 | GO:0031696 | alpha-2C adrenergic receptor binding(GO:0031696) |
| 7.0 | 21.0 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 6.9 | 27.8 | GO:0004341 | gluconolactonase activity(GO:0004341) |
| 6.8 | 20.5 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 6.8 | 6.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 6.7 | 26.8 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 6.5 | 26.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 6.3 | 18.8 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 6.2 | 24.8 | GO:0052596 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 6.2 | 6.2 | GO:0051373 | FATZ binding(GO:0051373) |
| 6.1 | 18.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 5.8 | 17.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 5.8 | 17.4 | GO:0017129 | triglyceride binding(GO:0017129) |
| 5.8 | 17.4 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 5.8 | 34.6 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
| 5.7 | 17.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 5.6 | 16.7 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
| 5.5 | 16.5 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 5.5 | 38.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 5.4 | 70.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 5.3 | 32.0 | GO:0030172 | troponin C binding(GO:0030172) |
| 5.3 | 15.8 | GO:0008431 | vitamin E binding(GO:0008431) |
| 5.2 | 47.2 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 5.0 | 20.0 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 4.9 | 4.9 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
| 4.8 | 19.4 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 4.8 | 4.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 4.7 | 42.5 | GO:0016015 | morphogen activity(GO:0016015) |
| 4.7 | 56.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 4.7 | 18.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 4.6 | 23.2 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
| 4.6 | 36.8 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 4.6 | 4.6 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 4.5 | 36.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 4.4 | 13.2 | GO:0046577 | long-chain-alcohol oxidase activity(GO:0046577) |
| 4.4 | 13.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 4.4 | 26.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 4.3 | 17.4 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 4.3 | 13.0 | GO:0070052 | collagen V binding(GO:0070052) |
| 4.3 | 12.9 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 4.3 | 21.5 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 4.3 | 29.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 4.3 | 17.1 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 4.2 | 16.7 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 4.2 | 37.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 4.2 | 20.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 4.2 | 12.5 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 4.1 | 12.4 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 4.1 | 12.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 4.0 | 8.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 4.0 | 16.0 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 4.0 | 16.0 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 3.9 | 11.8 | GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 3.9 | 15.7 | GO:0035939 | microsatellite binding(GO:0035939) |
| 3.8 | 34.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 3.8 | 15.1 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 3.8 | 15.0 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 3.8 | 18.8 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 3.7 | 22.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 3.7 | 33.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 3.6 | 18.2 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 3.6 | 3.6 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 3.6 | 3.6 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
| 3.6 | 24.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 3.5 | 17.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 3.5 | 17.5 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 3.5 | 14.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 3.5 | 10.5 | GO:0052854 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
| 3.5 | 10.4 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 3.4 | 3.4 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 3.3 | 6.7 | GO:0070888 | E-box binding(GO:0070888) |
| 3.3 | 9.9 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
| 3.3 | 13.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 3.3 | 13.2 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
| 3.3 | 39.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 3.2 | 9.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 3.2 | 15.9 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 3.2 | 9.5 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
| 3.1 | 15.7 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 3.1 | 15.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 3.1 | 3.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 3.1 | 12.4 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 3.1 | 12.4 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
| 3.1 | 9.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 3.1 | 12.2 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 3.0 | 12.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
| 3.0 | 9.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 3.0 | 15.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 3.0 | 14.9 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 3.0 | 26.9 | GO:0048495 | Roundabout binding(GO:0048495) |
| 3.0 | 8.9 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 3.0 | 3.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
| 3.0 | 3.0 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
| 2.9 | 23.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 2.9 | 35.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 2.9 | 17.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
| 2.9 | 45.9 | GO:0019841 | retinol binding(GO:0019841) |
| 2.9 | 34.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 2.8 | 8.4 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 2.8 | 8.4 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 2.8 | 8.4 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 2.8 | 14.0 | GO:1990254 | keratin filament binding(GO:1990254) |
| 2.8 | 8.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 2.8 | 11.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 2.8 | 22.2 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 2.8 | 16.5 | GO:0000182 | rDNA binding(GO:0000182) |
| 2.7 | 10.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 2.7 | 18.9 | GO:0036122 | BMP binding(GO:0036122) |
| 2.7 | 10.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 2.7 | 13.5 | GO:0005119 | smoothened binding(GO:0005119) |
| 2.7 | 40.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 2.7 | 61.7 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
| 2.6 | 5.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 2.6 | 10.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 2.6 | 26.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 2.6 | 206.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 2.5 | 28.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 2.5 | 2.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
| 2.5 | 12.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 2.5 | 32.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 2.5 | 32.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 2.5 | 9.9 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
| 2.4 | 9.7 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 2.4 | 9.7 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
| 2.4 | 33.9 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 2.4 | 14.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 2.4 | 4.7 | GO:0030305 | heparanase activity(GO:0030305) |
| 2.4 | 30.6 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 2.4 | 7.1 | GO:0004336 | galactosylceramidase activity(GO:0004336) |
| 2.3 | 37.4 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 2.3 | 7.0 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 2.3 | 58.0 | GO:0043274 | phospholipase binding(GO:0043274) |
| 2.3 | 25.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 2.3 | 37.0 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 2.3 | 16.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 2.3 | 11.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 2.3 | 32.1 | GO:0045159 | myosin II binding(GO:0045159) |
| 2.3 | 13.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 2.3 | 22.9 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 2.2 | 6.7 | GO:0047086 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
| 2.2 | 6.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 2.2 | 8.9 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) secondary active organic cation transmembrane transporter activity(GO:0008513) acetate ester transmembrane transporter activity(GO:1901375) |
| 2.2 | 8.9 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 2.2 | 15.6 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 2.2 | 6.6 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 2.2 | 17.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 2.2 | 8.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 2.2 | 6.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 2.2 | 19.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 2.1 | 10.7 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 2.1 | 10.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 2.1 | 8.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 2.1 | 4.2 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 2.1 | 27.1 | GO:0009374 | biotin binding(GO:0009374) |
| 2.1 | 12.5 | GO:0008142 | oxysterol binding(GO:0008142) |
| 2.1 | 24.9 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 2.1 | 16.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 2.1 | 8.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 2.1 | 14.4 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 2.1 | 6.2 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 2.0 | 18.4 | GO:0032190 | acrosin binding(GO:0032190) |
| 2.0 | 10.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 2.0 | 10.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 2.0 | 6.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 2.0 | 13.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 2.0 | 4.0 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 2.0 | 9.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 2.0 | 11.8 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 2.0 | 9.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 2.0 | 5.9 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 2.0 | 13.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 1.9 | 5.8 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 1.9 | 5.8 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 1.9 | 5.8 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 1.9 | 35.0 | GO:0038191 | neuropilin binding(GO:0038191) |
| 1.9 | 21.3 | GO:0031433 | telethonin binding(GO:0031433) |
| 1.9 | 5.8 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 1.9 | 73.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 1.9 | 9.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 1.9 | 11.2 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 1.9 | 11.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 1.9 | 22.3 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 1.9 | 59.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 1.8 | 5.5 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 1.8 | 7.4 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 1.8 | 12.8 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
| 1.8 | 12.8 | GO:0033691 | sialic acid binding(GO:0033691) |
| 1.8 | 10.9 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 1.8 | 7.2 | GO:0001626 | nociceptin receptor activity(GO:0001626) |
| 1.8 | 7.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 1.8 | 5.4 | GO:0061609 | fructose-1-phosphate aldolase activity(GO:0061609) |
| 1.8 | 5.4 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 1.8 | 32.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 1.8 | 14.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 1.8 | 5.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 1.8 | 24.5 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 1.7 | 7.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 1.7 | 81.7 | GO:0008009 | chemokine activity(GO:0008009) |
| 1.7 | 15.5 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 1.7 | 35.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 1.7 | 1.7 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
| 1.7 | 5.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 1.7 | 20.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 1.7 | 5.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 1.7 | 6.8 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 1.7 | 6.8 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 1.7 | 10.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 1.7 | 13.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 1.7 | 13.5 | GO:0071253 | connexin binding(GO:0071253) |
| 1.7 | 10.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 1.6 | 6.6 | GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
| 1.6 | 6.5 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 1.6 | 6.5 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 1.6 | 4.9 | GO:0070905 | serine binding(GO:0070905) |
| 1.6 | 21.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 1.6 | 4.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 1.6 | 9.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 1.6 | 30.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 1.6 | 6.4 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 1.6 | 11.1 | GO:0045545 | syndecan binding(GO:0045545) |
| 1.6 | 6.4 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
| 1.6 | 14.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 1.6 | 17.4 | GO:0005372 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
| 1.6 | 18.9 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 1.6 | 9.4 | GO:0070004 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
| 1.6 | 12.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 1.6 | 9.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 1.5 | 54.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 1.5 | 6.2 | GO:0045569 | TRAIL binding(GO:0045569) |
| 1.5 | 13.8 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 1.5 | 3.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 1.5 | 4.5 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 1.5 | 5.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 1.5 | 2.9 | GO:0042806 | fucose binding(GO:0042806) |
| 1.5 | 5.8 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 1.4 | 7.2 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 1.4 | 7.2 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
| 1.4 | 52.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 1.4 | 31.4 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 1.4 | 1.4 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
| 1.4 | 2.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 1.4 | 8.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 1.4 | 4.2 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 1.4 | 4.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 1.4 | 7.0 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 1.4 | 9.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 1.4 | 7.0 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 1.4 | 21.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 1.4 | 5.6 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
| 1.4 | 7.0 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 1.4 | 13.9 | GO:0043394 | proteoglycan binding(GO:0043394) |
| 1.4 | 8.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 1.4 | 138.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 1.4 | 4.1 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 1.4 | 12.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 1.4 | 4.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 1.4 | 4.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 1.4 | 4.1 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
| 1.4 | 6.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 1.4 | 4.1 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 1.4 | 6.8 | GO:0004875 | complement receptor activity(GO:0004875) |
| 1.3 | 10.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 1.3 | 4.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 1.3 | 166.2 | GO:0008201 | heparin binding(GO:0008201) |
| 1.3 | 10.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 1.3 | 10.6 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 1.3 | 4.0 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
| 1.3 | 9.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 1.3 | 34.3 | GO:0031489 | myosin V binding(GO:0031489) |
| 1.3 | 11.8 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 1.3 | 12.9 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
| 1.3 | 7.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 1.3 | 10.2 | GO:0008430 | selenium binding(GO:0008430) |
| 1.3 | 3.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 1.3 | 7.7 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 1.3 | 2.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 1.3 | 37.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 1.3 | 7.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 1.2 | 5.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 1.2 | 37.1 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 1.2 | 6.2 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 1.2 | 8.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 1.2 | 3.7 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 1.2 | 18.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 1.2 | 10.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 1.2 | 6.0 | GO:0052842 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 1.2 | 6.0 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 1.2 | 4.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 1.2 | 1.2 | GO:0035276 | ethanol binding(GO:0035276) |
| 1.2 | 8.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 1.2 | 23.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 1.2 | 5.8 | GO:0050610 | glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 1.2 | 3.5 | GO:0052815 | medium-chain acyl-CoA hydrolase activity(GO:0052815) long-chain acyl-CoA hydrolase activity(GO:0052816) |
| 1.2 | 11.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 1.2 | 34.8 | GO:0001848 | complement binding(GO:0001848) |
| 1.2 | 3.5 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 1.1 | 10.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 1.1 | 10.3 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 1.1 | 5.7 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 1.1 | 4.5 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 1.1 | 4.5 | GO:0038132 | neuregulin binding(GO:0038132) |
| 1.1 | 22.5 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 1.1 | 67.2 | GO:0030507 | spectrin binding(GO:0030507) |
| 1.1 | 8.9 | GO:0015232 | heme transporter activity(GO:0015232) |
| 1.1 | 10.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 1.1 | 15.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 1.1 | 6.7 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 1.1 | 33.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 1.1 | 4.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 1.1 | 11.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 1.1 | 8.9 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 1.1 | 23.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 1.1 | 12.2 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
| 1.1 | 50.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 1.1 | 3.3 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 1.1 | 8.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 1.1 | 3.3 | GO:0099589 | serotonin receptor activity(GO:0099589) |
| 1.1 | 4.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 1.1 | 5.5 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 1.1 | 9.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 1.1 | 3.3 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 1.1 | 37.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 1.1 | 5.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 1.1 | 22.6 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 1.1 | 5.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 1.1 | 3.2 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 1.1 | 24.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 1.1 | 9.6 | GO:0043426 | MRF binding(GO:0043426) |
| 1.1 | 7.4 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 1.0 | 4.2 | GO:0032567 | dGTPase activity(GO:0008832) triphosphoric monoester hydrolase activity(GO:0016793) guanyl deoxyribonucleotide binding(GO:0032560) dGTP binding(GO:0032567) |
| 1.0 | 19.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 1.0 | 15.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 1.0 | 5.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 1.0 | 76.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 1.0 | 4.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 1.0 | 45.7 | GO:0005518 | collagen binding(GO:0005518) |
| 1.0 | 66.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 1.0 | 5.8 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 1.0 | 11.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 1.0 | 3.9 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 1.0 | 11.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 1.0 | 4.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 1.0 | 2.9 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 1.0 | 5.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 1.0 | 5.7 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 1.0 | 9.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.9 | 3.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.9 | 5.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
| 0.9 | 15.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.9 | 3.7 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.9 | 8.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.9 | 5.6 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.9 | 4.6 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 0.9 | 221.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.9 | 3.7 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.9 | 5.5 | GO:0070728 | leucine binding(GO:0070728) |
| 0.9 | 11.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.9 | 4.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.9 | 9.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.9 | 6.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
| 0.9 | 35.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.9 | 2.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.9 | 4.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.9 | 14.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.9 | 19.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.9 | 7.7 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.9 | 5.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
| 0.9 | 23.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.8 | 2.5 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.8 | 2.5 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.8 | 4.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.8 | 6.7 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.8 | 2.5 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.8 | 8.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.8 | 11.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.8 | 4.9 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.8 | 9.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.8 | 2.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.8 | 5.7 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
| 0.8 | 14.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.8 | 13.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.8 | 6.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.8 | 20.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.8 | 16.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.8 | 2.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.8 | 3.2 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.8 | 2.4 | GO:0002113 | interleukin-33 binding(GO:0002113) |
| 0.8 | 3.2 | GO:0001093 | TFIIB-class transcription factor binding(GO:0001093) |
| 0.8 | 44.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.8 | 7.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.8 | 6.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.8 | 33.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.8 | 9.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 0.8 | 3.1 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.8 | 20.8 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.8 | 4.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.8 | 2.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.8 | 1.5 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
| 0.7 | 5.2 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.7 | 5.2 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.7 | 2.2 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.7 | 8.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.7 | 7.3 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.7 | 2.2 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.7 | 22.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.7 | 2.2 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 0.7 | 2.9 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.7 | 3.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.7 | 42.3 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
| 0.7 | 3.6 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.7 | 17.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.7 | 6.3 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.7 | 9.6 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.7 | 8.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.7 | 2.7 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.7 | 3.4 | GO:0010181 | FMN binding(GO:0010181) |
| 0.7 | 55.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.7 | 15.6 | GO:0004497 | monooxygenase activity(GO:0004497) |
| 0.7 | 4.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.7 | 6.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.7 | 12.0 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.7 | 2.7 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.7 | 2.0 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.7 | 2.6 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.7 | 3.3 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.7 | 1.3 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
| 0.7 | 6.5 | GO:0005549 | odorant binding(GO:0005549) |
| 0.6 | 1.9 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.6 | 9.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.6 | 5.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.6 | 11.6 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.6 | 2.6 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.6 | 10.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.6 | 7.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.6 | 3.2 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 0.6 | 16.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.6 | 2.5 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
| 0.6 | 4.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.6 | 99.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.6 | 9.3 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.6 | 1.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.6 | 3.7 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.6 | 2.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.6 | 2.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.6 | 2.4 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.6 | 1.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.6 | 4.2 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.6 | 6.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
| 0.6 | 4.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.6 | 2.9 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.6 | 4.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.6 | 1.7 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.6 | 1.7 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.6 | 14.4 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.6 | 5.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.6 | 5.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.6 | 11.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.6 | 87.5 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.6 | 51.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.6 | 5.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.6 | 2.8 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
| 0.6 | 1.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
| 0.5 | 8.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.5 | 4.4 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.5 | 5.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.5 | 2.7 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.5 | 2.6 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.5 | 21.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.5 | 2.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.5 | 3.6 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.5 | 15.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.5 | 3.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.5 | 7.7 | GO:0017022 | myosin binding(GO:0017022) |
| 0.5 | 5.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.5 | 0.5 | GO:0030249 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
| 0.5 | 9.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.5 | 13.9 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.5 | 45.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.5 | 2.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.5 | 1.0 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 0.5 | 7.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.5 | 2.9 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.5 | 20.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.5 | 2.4 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
| 0.5 | 1.4 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 0.5 | 1.9 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 0.5 | 4.2 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.5 | 17.1 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
| 0.5 | 1.8 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.5 | 4.1 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.5 | 1.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.5 | 5.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.5 | 11.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.5 | 3.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.5 | 2.7 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.4 | 1.3 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.4 | 3.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.4 | 8.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.4 | 8.6 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.4 | 1.7 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.4 | 6.8 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.4 | 1.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.4 | 4.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.4 | 1.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.4 | 2.8 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.4 | 6.3 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
| 0.4 | 3.9 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.4 | 2.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.4 | 1.2 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.4 | 1.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.4 | 2.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.4 | 10.0 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.4 | 19.2 | GO:0005254 | chloride channel activity(GO:0005254) |
| 0.4 | 0.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.4 | 1.1 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.4 | 29.3 | GO:0005179 | hormone activity(GO:0005179) |
| 0.4 | 4.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.4 | 5.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.4 | 4.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.4 | 32.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.4 | 1.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.4 | 1.1 | GO:0036505 | prosaposin receptor activity(GO:0036505) |
| 0.3 | 3.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.3 | 2.1 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.3 | 3.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
| 0.3 | 37.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.3 | 15.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.3 | 4.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.3 | 5.3 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.3 | 1.7 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) |
| 0.3 | 2.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.3 | 9.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.3 | 8.1 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.3 | 2.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.3 | 4.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.3 | 1.8 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.3 | 0.9 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.3 | 1.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.3 | 0.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.3 | 1.1 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.3 | 0.8 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.3 | 6.0 | GO:0042166 | acetylcholine binding(GO:0042166) |
| 0.3 | 1.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.3 | 3.3 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.3 | 2.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.3 | 0.8 | GO:0008903 | hydroxypyruvate isomerase activity(GO:0008903) |
| 0.3 | 4.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.3 | 0.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.3 | 1.5 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.3 | 1.0 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.2 | 2.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.2 | 6.5 | GO:0004601 | peroxidase activity(GO:0004601) |
| 0.2 | 0.7 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
| 0.2 | 2.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.2 | 7.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.2 | 1.0 | GO:0019825 | oxygen binding(GO:0019825) |
| 0.2 | 0.2 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.2 | 1.0 | GO:0005343 | organic acid:sodium symporter activity(GO:0005343) |
| 0.2 | 0.7 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.2 | 10.8 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.2 | 0.5 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 0.2 | 0.5 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
| 0.2 | 127.6 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.2 | 0.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.2 | 0.7 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.2 | 0.7 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.2 | 2.4 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
| 0.2 | 1.5 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.2 | 3.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.2 | 0.6 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) |
| 0.2 | 1.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.2 | 0.6 | GO:0004314 | [acyl-carrier-protein] S-malonyltransferase activity(GO:0004314) 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) phosphopantetheine binding(GO:0031177) |
| 0.2 | 6.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.2 | 1.2 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
| 0.2 | 1.3 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.2 | 2.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.2 | 0.5 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 0.2 | 1.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.2 | 1.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.2 | 37.9 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
| 0.2 | 0.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.2 | 0.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.2 | 0.6 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) |
| 0.2 | 0.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.2 | 0.5 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.2 | 4.6 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.2 | 1.5 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 1.0 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
| 0.1 | 4.3 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
| 0.1 | 1.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.1 | 2.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 1.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.1 | 0.6 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 0.1 | 3.9 | GO:0019955 | cytokine binding(GO:0019955) |
| 0.1 | 0.9 | GO:0022843 | voltage-gated cation channel activity(GO:0022843) |
| 0.1 | 6.3 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.1 | 0.7 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.1 | 0.4 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.1 | 5.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 0.5 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.1 | 1.0 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.1 | 0.9 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.1 | 4.3 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
| 0.1 | 0.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.1 | 1.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.1 | 0.9 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.1 | 1.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.1 | 0.5 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.1 | 0.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.1 | 0.4 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.1 | 1.0 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 0.4 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) interleukin-3 receptor binding(GO:0005135) |
| 0.1 | 0.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.1 | 2.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.1 | 3.2 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.1 | 0.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 0.1 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 0.1 | 75.2 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.1 | 0.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.6 | GO:0005272 | sodium channel activity(GO:0005272) |
| 0.0 | 0.8 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.0 | 0.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.0 | 1.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.0 | 0.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.0 | 0.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 10.0 | 10.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 3.0 | 41.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 2.8 | 2.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 2.6 | 578.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 2.6 | 181.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 2.4 | 11.8 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 2.3 | 13.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 2.2 | 92.9 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 2.0 | 7.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 1.9 | 38.5 | PID CDC42 PATHWAY | CDC42 signaling events |
| 1.8 | 113.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 1.7 | 301.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 1.7 | 72.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 1.6 | 42.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 1.5 | 9.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 1.5 | 408.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 1.5 | 23.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 1.4 | 94.6 | PID FGF PATHWAY | FGF signaling pathway |
| 1.3 | 18.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 1.3 | 51.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 1.2 | 11.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 1.2 | 56.8 | ST ADRENERGIC | Adrenergic Pathway |
| 1.1 | 7.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 1.1 | 23.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 1.0 | 44.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 1.0 | 11.1 | PID NOTCH PATHWAY | Notch signaling pathway |
| 1.0 | 22.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 1.0 | 49.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.9 | 38.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.8 | 17.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.8 | 10.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.8 | 44.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.7 | 18.0 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.7 | 20.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.7 | 6.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.7 | 8.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.7 | 13.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.7 | 14.3 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.6 | 11.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.6 | 22.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.6 | 31.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.6 | 41.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.6 | 26.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.6 | 7.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.6 | 8.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.6 | 5.9 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.6 | 6.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.6 | 6.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.6 | 3.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.5 | 3.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.5 | 2.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.5 | 8.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.5 | 3.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.5 | 2.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.5 | 153.5 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
| 0.5 | 4.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.4 | 1.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.4 | 1.8 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.4 | 5.8 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.3 | 2.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.3 | 2.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.3 | 6.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.3 | 10.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.3 | 6.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.3 | 4.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.3 | 13.0 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.3 | 2.8 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.2 | 6.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.2 | 4.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.2 | 9.3 | PID BMP PATHWAY | BMP receptor signaling |
| 0.2 | 4.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.2 | 1.8 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.2 | 1.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.2 | 3.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.2 | 2.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.2 | 9.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.2 | 5.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.2 | 2.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.2 | 5.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.2 | 4.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.2 | 3.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.2 | 0.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.1 | 2.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 2.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 8.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 2.4 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.1 | 1.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.1 | 0.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.1 | 6.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 1.7 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.1 | 5.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.1 | 1.2 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.1 | 1.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.1 | 2.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 1.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.1 | 0.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.1 | 0.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.0 | 1.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.0 | 0.7 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.0 | 2.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 0.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.0 | 2.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.7 | 96.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 5.2 | 57.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 4.5 | 81.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 3.8 | 84.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 3.5 | 14.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 3.5 | 27.6 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 3.3 | 43.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 2.8 | 50.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 2.8 | 66.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 2.7 | 129.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 2.7 | 68.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 2.7 | 40.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 2.3 | 4.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 2.3 | 51.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 2.3 | 34.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 2.2 | 52.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 2.1 | 57.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 2.1 | 31.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 2.0 | 14.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 1.9 | 24.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 1.9 | 29.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 1.7 | 17.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 1.7 | 59.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 1.7 | 78.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 1.7 | 3.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 1.7 | 28.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 1.6 | 33.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 1.6 | 14.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 1.6 | 17.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 1.6 | 21.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 1.5 | 28.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 1.5 | 54.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 1.5 | 14.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 1.5 | 20.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 1.5 | 10.2 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
| 1.4 | 30.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 1.4 | 44.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 1.3 | 60.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 1.3 | 3.9 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| 1.3 | 20.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 1.3 | 81.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 1.2 | 26.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 1.2 | 86.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 1.2 | 2.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 1.2 | 5.8 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 1.2 | 20.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 1.2 | 28.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 1.1 | 227.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 1.1 | 81.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 1.1 | 4.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 1.1 | 7.8 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 1.1 | 1.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 1.0 | 12.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 1.0 | 36.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 1.0 | 11.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 1.0 | 12.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 1.0 | 39.6 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 1.0 | 51.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.9 | 12.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.9 | 17.8 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.9 | 6.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.9 | 85.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.9 | 17.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.9 | 29.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.9 | 22.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.9 | 2.7 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.9 | 4.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.9 | 18.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.9 | 9.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.9 | 22.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.9 | 15.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.9 | 2.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.9 | 14.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.8 | 46.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.8 | 8.8 | REACTOME OPSINS | Genes involved in Opsins |
| 0.8 | 2.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.8 | 14.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.8 | 17.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.7 | 28.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.7 | 33.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.7 | 18.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.7 | 26.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.7 | 4.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.7 | 12.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.7 | 5.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.6 | 10.4 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.6 | 7.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.6 | 10.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.6 | 5.7 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.6 | 3.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
| 0.6 | 47.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.6 | 16.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.6 | 6.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.6 | 24.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.6 | 9.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.6 | 23.7 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.6 | 26.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.6 | 11.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.6 | 2.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.6 | 70.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.5 | 3.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.5 | 19.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.5 | 13.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.5 | 44.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.5 | 12.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.5 | 10.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.5 | 20.3 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
| 0.5 | 1.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.4 | 0.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.4 | 5.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.4 | 1.7 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.4 | 11.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.4 | 23.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.4 | 16.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.4 | 6.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
| 0.4 | 37.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.4 | 5.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.4 | 23.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.4 | 3.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.4 | 1.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.3 | 6.7 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.3 | 3.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.3 | 6.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.3 | 4.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.3 | 1.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.3 | 3.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.3 | 97.4 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.3 | 5.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.3 | 6.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.3 | 3.0 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.3 | 0.8 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.3 | 0.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.3 | 0.5 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
| 0.3 | 6.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.2 | 1.2 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
| 0.2 | 4.7 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
| 0.2 | 3.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.2 | 11.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.2 | 10.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.2 | 6.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.2 | 3.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.2 | 8.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.2 | 1.7 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.2 | 5.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.2 | 16.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.2 | 2.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.1 | 3.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 0.9 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
| 0.1 | 5.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.1 | 2.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 3.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.1 | 0.9 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
| 0.1 | 0.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 0.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 0.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.0 | 0.4 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
| 0.0 | 0.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.0 | 0.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.0 | 1.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.0 | 0.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.0 | 0.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.0 | 0.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |